Contracts With Patients in Clinical Practice
“Contracts With Patients in Clinical Practice” – The Lancet
“Contracts With Patients in Clinical Practice” – The Lancet
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Research led by Stacey McMorrow (a former student of mine) shows that Obamacare was especially helpful in enabling black and Hispanic people obtain healthcare insurance: Disparities in insurance rates among either groups are declining:
Good medical outcomes often depends on good nursing care. When hospitals cut back on nursing care, patient mortality rates climb. If you want a good hospital, pick one that doesn’t skimp on the nurse-to-patient ratio. You should also look at the education level of nurses a hospital employs. Because not all nurses are equally skilled….
Among people receiving hospice care, the last few days of life can be intense, with progression of pain or breathing problems or other symptoms of their terminal illnesses. For those who die on Sundays, that means they are less likely to see doctors or nurses in the last days of life:
“Specialty drugs” – that’s what they’re called. Not the pills of old, these pharmaceuticals are often given intravenously or through injection. Often more biologic in their synthesis than chemical, they are expensive to produce and often target narrow disease processes, meaning the number of patients likely to benefit from them is much much smaller than,…
Recently, I showed some data illustrating the rapid growth in healthcare jobs in the United States, compared to jobs in other parts of the economy. Here’s a picture, courtesy of Dan Diamond, showing that this growth has not been steady. Instead, the growth of hospital jobs in the US stalled for a while, before taking…